FDA Approves Pfizer’s RSV Vaccine For Older Adults—It Could Be Available This Fall

Forbes June 1, 2023
Robert Hart

Topline

The Food and Drug Administration on Wednesday approved Pfizer’s vaccine to protect older adults from RSV, weeks after the agency greenlit the very first shot against the common and potentially lethal infection following decades of unsuccessful attempts and numerous setbacks.

Key Facts

Crucial Quote

“A vaccine to help prevent RSV had been an elusive public health goal for more than half a century,” said Annaliesa Anderson, senior vice president and chief scientific officer for vaccine research and development at Pfizer. Anderson said the shot “will address a need to help protect older adults against the potentially serious consequences of RSV disease.”

News Peg

Pfizer’s shot is only the second vaccine authorized against RSV in the U.S. after the FDA...

Today's Sponsors

Today's Sponsor